These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 910158)

  • 1. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
    Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat.
    Becci PJ; Thompson HJ; Grubbs CJ; Brown CC; Moon RC
    Cancer Res; 1979 Aug; 39(8):3141-4. PubMed ID: 455298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
    Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat.
    Sporn MB; Squire RA; Brown CC; Smith JM; Wenk ML; Springer S
    Science; 1977 Feb; 195(4277):487-9. PubMed ID: 835006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
    J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
    Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
    Komatsu H; Kakizoe T; Nishio Y; Honma Y; Niijima T
    Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
    [No Abstract]   [Full Text] [Related]  

  • 9. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
    Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
    Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A technique for multiparametric analysis of hemodynamic changes in rat urinary bladder during carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Lurie AG; Rippey RM; Conran PB; Tatematsu M; Ito N
    Gan; 1979 Oct; 70(5):717-8. PubMed ID: 520763
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet.
    Irving CC; Tice AJ; Murphy WM
    Cancer Res; 1979 Aug; 39(8):3040-3. PubMed ID: 455288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
    Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
    Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cis-diamminedichloroplatinum (II) (CDDP) on bladder cancer on rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)].
    Miyakawa M; Yoshida O
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):258-62. PubMed ID: 6820893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids.
    Becci PJ; Thompson HJ; Strum JM; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
    Kunze E; Schulz H; Adamek M; Gabius HJ
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ito N; Shirai T; Fukushima S; Hirose M
    J Cancer Res Clin Oncol; 1984; 108(1):169-73. PubMed ID: 6746710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
    Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
    Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.